Lyra Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Lyra Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Lyra Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $136K, a 52.1% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Depreciation for 2023 was $278K, a 73.9% decline from 2022.
  • Lyra Therapeutics, Inc. annual Depreciation for 2022 was $1.07M, a 6.59% increase from 2021.
  • Lyra Therapeutics, Inc. annual Depreciation for 2021 was $1M, a 954% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $278K -$789K -73.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $1.07M +$66K +6.59% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $1M +$906K +954% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $95K +$68K +252% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $27K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.